MUTYH and colorectal carcinoma: Since biallelic MUTYH mutations confer a spontaneous mutator phenotype in human cell lines [7, 8] and in mice [9, 10], it is generally regarded that MUTYH inactivation in MAP patients drives genomic instability in colorectal epithelial cells thereby increasing CRC risk.